Graphical Research.jpg
Cannabidiol (CBD) Market Trends 2021 | North America, Europe, & APAC Industry Forecasts 2027: Graphical Research
June 02, 2021 06:00 ET | Graphical Research
Pune, India, June 02, 2021 (GLOBE NEWSWIRE) -- The global cannabidiol market size is anticipated to expand at substantial CAGR during the forecast period as CBD is quite famous for treating large...
Graphical Research.jpg
Sleep Tech Devices Market Trends 2021 | North America, Europe, & APAC Industry Forecasts 2027: Graphical Research
May 10, 2021 06:00 ET | Graphical Research
Pune, India, May 10, 2021 (GLOBE NEWSWIRE) -- The global sleep tech devices market size is predicted to show tremendous growth during the forecast period owing to the growing need among...
SleepCharge by Nox Health Expands Cognitive Behavioral Therapy Program for Insomnia
October 06, 2020 08:00 ET | SleepCharge
ATLANTA, Oct. 06, 2020 (GLOBE NEWSWIRE) -- SleepCharge by Nox Health has announced the next evolution of its program for Cognitive Behavioral Therapy for Insomnia (CBTi). The new program called...
Insomnia Awareness Night to Shed Light on Impact of Sleeplessness
June 15, 2020 08:05 ET | American Academy of Sleep Medicine
DARIEN, Ill., June 15, 2020 (GLOBE NEWSWIRE) -- June features the shortest nights of the year, but for those living with chronic insomnia, every night is long. That’s why the American Academy of...
gmi 2018.png
Sleep Tech Devices Market value to cross $27 billion by 2025: Global Market Insights, Inc.
November 05, 2019 05:00 ET | Global Market Insights, Inc
Selbyville, Delaware, Nov. 05, 2019 (GLOBE NEWSWIRE) -- Global Sleep Tech Devices Market is projected to surpass USD 27 billion by 2025, according to a new research report by Global Market...
Minerva logo
Minerva Neurosciences Reports Second Quarter 2019 Financial Results and Business Updates
August 05, 2019 07:30 ET | Minerva Neurosciences, Inc
During the Second Quarter, Minerva announced several important clinical advancements, including positive top line results from two Phase 2b studies of seltorexant (MIN-202) in major depressive...
Dave Kenney Certified as a Brain Health Coach by Amen Clinics
July 16, 2019 08:00 ET | Emergo Recovery
BARRIE, Ontario, July 16, 2019 (GLOBE NEWSWIRE) -- Dave Kenney, Executive Director and CEO at Emergo Recovery, has been certified by Amen Clinics as a Brain Health Coach. The Brain Health Coaching...
Minerva logo
Minerva Neurosciences Announces Achievement of Primary and Key Secondary Objectives in Phase 2b Clinical Trial of Seltorexant (MIN-202) in Insomnia
June 24, 2019 07:30 ET | Minerva Neurosciences, Inc
Primary endpoint, defined as Latency to Persistent Sleep (LPS) at Night 1, showed improvement with a p-value ≤0.001 after treatment with 10 and 20 mg doses of seltorexantKey secondary endpoint,...
Minerva logo
Minerva Neurosciences to Host Live Conference Call and Webcast With Key Opinion Leaders to Discuss Successful Insomnia Trial With Seltorexant
June 23, 2019 17:30 ET | Minerva Neurosciences, Inc
Call scheduled for 8:30 a.m. Eastern Time on June 24 to review results of successful Phase 2b trial showing achievement of primary and secondary endpoints with potential first-in-class specific...
Major New Digital CBT Study Links Better Sleep To Better Overall Health
September 25, 2018 11:00 ET | Big Health
SAN FRANCISCO, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Digital programs for improving sleep may improve overall health as well, according to new research published in JAMA Psychiatry. In a year-long...